Original language | English |
---|---|
Pages (from-to) | A7-A8 |
Journal | American Journal of Kidney Diseases |
Volume | 73 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 1 2019 |
ASJC Scopus subject areas
- Nephrology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: American Journal of Kidney Diseases, Vol. 73, No. 3, 01.03.2019, p. A7-A8.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - US Renal Data System 2018 Annual Data Report
T2 - Epidemiology of Kidney Disease in the United States
AU - Saran, Rajiv
AU - Robinson, Bruce
AU - Abbott, Kevin C.
AU - Agodoa, Lawrence Y.C.
AU - Bragg-Gresham, Jennifer
AU - Balkrishnan, Rajesh
AU - Bhave, Nicole
AU - Dietrich, Xue
AU - Ding, Zhechen
AU - Eggers, Paul W.
AU - Gaipov, Abduzhappar
AU - Gillen, Daniel
AU - Gipson, Debbie
AU - Gu, Haoyu
AU - Guro, Paula
AU - Haggerty, Diana
AU - Han, Yun
AU - He, Kevin
AU - Herman, William
AU - Heung, Michael
AU - Hirth, Richard A.
AU - Hsiung, Jui Ting
AU - Hutton, David
AU - Inoue, Aya
AU - Jacobsen, Steven J.
AU - Jin, Yan
AU - Kalantar-Zadeh, Kamyar
AU - Kapke, Alissa
AU - Kleine, Carola Ellen
AU - Kovesdy, Csaba P.
AU - Krueter, William
AU - Kurtz, Vivian
AU - Li, Yiting
AU - Liu, Sai
AU - Marroquin, Maria V.
AU - McCullough, Keith
AU - Molnar, Miklos Z.
AU - Modi, Zubin
AU - Montez-Rath, Maria
AU - Moradi, Hamid
AU - Morgenstern, Hal
AU - Mukhopadhyay, Purna
AU - Nallamothu, Brahmajee
AU - Nguyen, Danh V.
AU - Norris, Keith C.
AU - O'Hare, Ann M.
AU - Obi, Yoshitsugu
AU - Park, Christina
AU - Pearson, Jeffrey
AU - Pisoni, Ronald
N1 - Funding Information: Funding for the USRDS Coordinating Center is provided under contract to University of Michigan Kidney Epidemiology and Cost Center ( HHSN 276201400001C ). Funding Information: Dr Balkrishnan receives consulting income from Merck and Company. Dr Bragg-Gresham is a consultant with the Medical Education Institute (MEI) involving quality-of-life performance measures. Dr Herman is chair of the Data Safety Monitoring Board for Merck Sharp & Dohme. Dr Kalantar-Zadeh has financial interests with the following entities: Abbott, AbbVie, Alexion, Amgen, AstraZeneca, Aveo, Chugai, DaVita, Fresenius, Genentech, Haymarket Media, Hospira, Kabi, Keryx, Novartis, Pfizer, Relypsa, Resverlogix, Sandoz, Sanofi, Shire, Vifor, UpToDate, and ZS Pharma. Dr Kovesdy is a consultant for AstraZeneca, Bayer, and Sanofi-Aventis. Dr Morgenstern is a consultant at Arbor Research Collaborative for Health. Dr O’Hare received grant funding from NIH, CDC, VA HSR&D; she also received speaker fees and honoraria from Dialysis Clinic Inc., Fresenius Medical Care, the University of Alabama at Birmingham, the University of Pennsylvania, and the Hammersmith Hospital in London. Dr Sim has investigator-initiated research grants from Keryx Pharmaceuticals, Mallinckrodt Pharmaceuticals, and Otsuka Pharmaceuticals. The remaining authors declare that they have no relevant financial interests. Funding Information: Funding for the USRDS Coordinating Center is provided under contract to University of Michigan Kidney Epidemiology and Cost Center (HHSN 276201400001C).
PY - 2019/3/1
Y1 - 2019/3/1
UR - http://www.scopus.com/inward/record.url?scp=85061530080&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061530080&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2019.01.001
DO - 10.1053/j.ajkd.2019.01.001
M3 - Editorial
AN - SCOPUS:85061530080
SN - 0272-6386
VL - 73
SP - A7-A8
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 3
ER -